Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer
Conditions: Colorectal Cancer - Metastatic Cancer
1 Location available
- E7389 in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Bladder Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
24 Locations available
- Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Fatigue - Metastatic Cancer - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity
14 Locations available
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
227 Locations available
- Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
4 Locations available
- Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients
Conditions: Breast Cancer
2 Locations available
- Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
Conditions: Liver Cancer - Metastatic Cancer
1 Location available
- Erlotinib and Stereotactic Body Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Non-Small Call Lung Cancer
Conditions: Lung Cancer
2 Locations available
- Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
Conditions: Leukemia - Non-melanomatous Skin Cancer
3 Locations available
- Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer
Conditions: Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)
5 Locations available
- MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
1 Location available
- Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer - Prostate Cancer
1 Location available
- A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
Conditions: Hedgehog Pathway - Smoothened - Basal Cell Carcinoma (BCC) - Basal Cell Nevoid Syndrome (BCNS)
2 Locations available
- A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
Conditions: Metastatic Pancreatic Cancer
1 Location available
- Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Conditions: Kidney Cancer
1 Location available
- Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
Conditions: Chemotherapeutic Agent Toxicity - Colorectal Cancer - Diarrhea
2 Locations available
- Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
Conditions: Locally Advanced (Unresectable) Pancreatic Cancer - Metastatic Pancreatic Cancer
3 Locations available
- A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined
Conditions: Metastatic Colorectal Cancer
23 Locations available
- Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer - Breast Neoplasms - Breast Tumors - Cancer - Locally Recurrent and Metastatic Breast Cancer - Metastases - Metastatic Cancer - Oncology - Solid Tumors - Tumors
5 Locations available
- Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Conditions: Pancreatic Cancer
2 Locations available
- Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Conditions: Pancreatic Neoplasms
1 Location available
- Naltrexone in Treating Women With Metastatic Breast Cancer That Did Not Respond to Hormone Therapy
Conditions: Breast Cancer
1 Location available
- Spousal Relationships and Pain in Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinic
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Adults - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Metastatic Cancer - Neurofibromatosis Type
1 Location available
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Conditions: Cancer
1 Location available
- Sorafenib and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
Conditions: Prostate Cancer
1 Location available
- Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Liver Cancer - Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
9 Locations available
- Combination Chemotherapy Followed By Docetaxel or Ixabepilone in Treating Patients Who Have Undergone Surgery for Nonmetastatic Breast Cancer
Conditions: Breast Cancer
17 Locations available
- Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)
Conditions: Metastatic Colorectal Cancer
1 Location available
- AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or O
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer
1 Location available
- Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Conditions: Kidney Neoplasms - Kidney (Renal Cell) Cancer
1 Location available
- Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Conditions: Advanced Metastatic Carcinoma
1 Location available
- Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT
Conditions: Breast Cancer - Breast Cancer Early Stage Breast Cancer (Stage 1-3) - Breast Cancer Metastatic Breast Cancer
1 Location available
- AZD0530 in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer
8 Locations available
- ABT-888 and Cyclophosphamide With Versus Without Doxorubicin in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
Conditions: Breast Cancer - Lymphoma - Lymphoproliferative Disorder - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Neuropsychological Measures in Patients Undergoing Radiation Therapy for Brain Metastases
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Psychosocial Effects of Cancer and Its Treatment - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Stereotactic Body Radiation Therapy and Vertebroplasty in Treating Patients With Localized Spinal Metastasis
Conditions: Metastatic Cancer - Pain - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
Conditions: Liver Cancer - Metastatic Cancer
1 Location available
- Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
Conditions: Kidney Cancer
1 Location available
- FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
Conditions: Esophageal Cancer - Lung Cancer - Malignant Mesothelioma - Metastatic Cancer
2 Locations available
- Melphalan With BBBD in Treating Patients With Brain Malignancies
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Metastatic Cancer
1 Location available
- FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
Conditions: Kidney Cancer - Lung Cancer - Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer
Conditions: Advanced and/or Metastatic Solid Organ Cancer
3 Locations available
- Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura
Conditions: Lung Cancer - Metastatic Cancer
1 Location available
- Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
2 Locations available
- Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
Conditions: Metastatic Breast Cancer
1 Location available
- Vaccine Therapy and GM-CSF in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Conditions: Pancreatic Cancer
1 Location available
- Personalized Treatment Selection for Dasatinib in Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
14 Locations available
- Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
Conditions: Kidney Cancer
1 Location available
- Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
Conditions: Head and Neck Cancer
18 Locations available
- Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer
5 Locations available
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
440 Locations available
- Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melan
Conditions: Kidney Cancer - Melanoma (Skin)
1 Location available
- Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Conditions: Colorectal Cancer - Head and Neck Cancer - Neoplasm Metastasis
3 Locations available
- Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
Conditions: Metastatic Cancer - Pain
35 Locations available
- Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cance
Conditions: Metastatic Breast Cancer
3 Locations available
- Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Conditions: Brain and Central Nervous System Tumors - Metastatic Cancer
2 Locations available
- Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer
Conditions: Colorectal Cancer - Metastatic Cancer
2 Locations available
- Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Conditions: Metastatic Melanoma - Renal Cell Cancer
1 Location available
- Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity
Conditions: Breast Cancer
1 Location available
- Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Conditions: Colorectal Cancer - Metastatic Cancer
1 Location available
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Conditions: Gastroesophageal Junction Adenocarcinoma - Gastric Cancer
15 Locations available
- Study of Combined Fulvestrant and RAD001 in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Conditions: Breast Cancer
1 Location available
- Irinotecan and ABT-888 in Treating Patients With Metastatic or Unresectable Cancer
Conditions: Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases
Conditions: Breast Cancer - Metastatic Cancer
1 Location available
- Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
Conditions: Metastatic Melanoma - Metastatic Renal Cell Cancer - Metastatic Cancer
1 Location available
- Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
1 Location available
- Vaccine Therapy and Aldesleukin in Treating Women With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
11 Locations available
- Cetuximab and/or Dasatinib in Treating Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
Conditions: Colorectal Cancer - Metastatic Cancer
2 Locations available
- Pioglitazone as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Treatment With Gemcitabine
Conditions: Pancreatic Cancer
1 Location available
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
157 Locations available
- Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar
Conditions: Pancreatic Cancer Stage IVA
1 Location available
- DNA Analysis of Tumor Tissue Samples From Patients With Recurrent or Metastatic Breast Cancer That Expresses HER2
Conditions: Breast Cancer
1 Location available
- Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade
Conditions: Prostate Cancer
1 Location available
- A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel and Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer, Locally Recurrent Breast Cancer
1 Location available
- Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Conditions: Head and Neck Cancer
9 Locations available
- Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer
Conditions: Kidney Cancer
7 Locations available
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
654 Locations available
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
127 Locations available
- AZD2171 in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
1 Location available
- Breast Imaging Using Indium In 111 CHX-A DTPA Trastuzumab in Patients With Primary Cancer or Metastatic Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy
Conditions: Liver Cancer - Metastatic Cancer
3 Locations available
- Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
1 Location available
- Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-
Conditions: Metastatic Breast Cancer
28 Locations available
- A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Neoplasms
1 Location available
- Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Conditions: Gastrointestinal Carcinoid Tumor - Islet Cell Tumor - Metastatic Cancer
1 Location available
- Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
Conditions: Metastatic Breast Cancer
3 Locations available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Autoantibody Blood Test in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
Conditions: Kidney Cancer
1 Location available
- Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer.
Conditions: Metastatic Breast Cancer - Metastases, Brain
1 Location available
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Conditions: Adrenocortical Carcinoma
18 Locations available
- A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffe
Conditions: Solid Cancers
3 Locations available
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors
Conditions: Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer
Conditions: Prostate Cancer
2 Locations available
- A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer
Conditions: Metastatic Prostate Cancer
1 Location available
- Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor
Conditions: Metastatic Cancer
1 Location available
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Kidney Cancer - Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Doxorubicin, Cyclophosphamide, and/or Paclitaxel in Treating Women With Nonmetastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors
Conditions: Neuroendocrine Cancer - Small Cell Lung Cancer - Non-Small Cell Lung Cancer - Gastric Cancer
1 Location available
- BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
Conditions: Metastatic Colorectal Cancer - EGFR-Expressing Metastatic CRC
1 Location available
- A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
Conditions: Breast Cancer
2 Locations available
- Bicalutamide in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
8 Locations available
- FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
1 Location available
- Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer
Conditions: Gastroesophageal Cancer - Gastric Cancer
2 Locations available
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Hereditary Clear Cell Renal Cell Carcinoma - Kidney Cancer
1 Location available
- A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Conditions: Advanced or Metastatic Solid Tumors - Advanced or Metastatic Breast Cancer
1 Location available
- Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer
Conditions: Breast Cancer - Chemotherapeutic Agent Toxicity - Palmar-Plantar Erythrodysesthesia
1 Location available
- Trial of RAD001 in Triple Negative Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- Gene Therapy in Treating Women With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors - Cancer - Solid Cancers
4 Locations available
- PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
Conditions: Cancer - Colon Cancer - Colorectal Cancer - Fever - Locally Advanced - Metastatic Colorectal Cancer - Neutropenia - Rectal Cancer
47 Locations available
- A Study of Paclitaxel/Carboplatin With or Without IMC-3G3 in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non-Small Cell Lung Cancer
21 Locations available
- Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Conditions: Kidney Neoplasms
17 Locations available
- Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy
Conditions: Lung Cancer - Radiation Toxicity
1 Location available
- Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer
Conditions: Cervical Cancer
1 Location available
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Conditions: ErbB2 Overexpressing - Solid Tumors - Metastatic Breast Cancer - Neoplasms, Breast
8 Locations available
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
293 Locations available
- A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving
Conditions: Breast Cancer - Neoplasm Metastasis
1 Location available
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Breast Cancer - Cognitive/Functional Effects - Lung Cancer - Metastatic Cancer - Prostate Cancer
41 Locations available
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms Tumor
Conditions: Kidney Cancer - Metastatic Cancer
171 Locations available
- Combination Chemotherapy and Bevacizumab in Treating Patients With Recurrent, Unresectable, or Metastatic Gastric Cancer, Gastroesophageal Junction Ca
Conditions: Esophageal Cancer - Gastric Cancer
1 Location available
- Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Treating Patients With Colorectal Cancer That Has Spr
Conditions: Colorectal Cancer - Metastatic Cancer
1 Location available
- Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
Conditions: Prostate Cancer
2 Locations available
- Sunitinib in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Conditions: Kidney Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients Previously Treated With Docetaxel
Conditions: Prostate Cancer - Pain
1 Location available
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
420 Locations available
- Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy
Conditions: Bladder Cancer
4 Locations available
- Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
Conditions: Metastatic Liver Cancer
1 Location available
- Vaccine Therapy and Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Liver Metastases Due to Colorectal Cancer
Conditions: Colorectal Cancer - Metastatic Cancer
1 Location available
- Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
Conditions: Bladder Cancer
3 Locations available
- Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Mitotane With or Without IMC-A12 in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Conditions: Adrenocortical Carcinoma
4 Locations available
- Stereotactic Radiosurgery in Treating Patients With Brain Metastases
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194
Conditions: Breast Cancer
1 Location available
- Randomized Phase II Trial of Trastuzumab or EVEROLIMUS in Hormone-refractory Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Andr
Conditions: Cancer - Cataract - Low Bone Mineral Density - Osteopenia - Osteoporosis - Prostate Cancer
34 Locations available
- Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
Conditions: Brain Cancer - Neoplasm Metastasis - Cancer of Brain and Nervous System - Metastatic Malignant Neoplasm to Brain
1 Location available
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
231 Locations available
- Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Phase II Gemzar, Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA
Conditions: Breast Cancer - Breast Cancer Metastatic Breast Cancer
1 Location available
- Advanced Care Planning Using the Five Wishes Document in Young Patients With Metastatic, Recurrent, or Progressive Cancer or HIV Disease
Conditions: Psychosocial Effects of Cancer and Its Treatment - Transitional Care Planning - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
2 Locations available
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Intraocular Melanoma - Lung Cancer - Melanoma (Skin) - Metastatic Cancer - Neuroblastoma - Ovarian Cancer - Retinoblastoma - Sarcoma - Small Intestine Cancer
1 Location available
- Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
Conditions: Kidney Cancer
1 Location available
- Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma
Conditions: Bladder Cancer
1 Location available
- Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
Conditions: Breast Cancer
4 Locations available
- Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
Conditions: Breast Cancer - Metastatic Cancer
1 Location available
- Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung
Conditions: Lung Cancer
1 Location available
- Isolation and Culture of Circulating Tumor Cells From Peripheral Blood
Conditions: Metastatic Cancer
1 Location available
- Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer
6 Locations available
- Chemotherapeutic Agents in Brain/Breast
Conditions: Breast Cancer - Metastatic Cancer
2 Locations available
- Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Stereotactic Radiosurgery in Treating Patients With Spinal Metastases
Conditions: Metastatic Cancer
1 Location available
- Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Conditions: Breast Cancer - Hypercalcemia of Malignancy - Colon Cancer - Endocrine Cancer - Head and Neck Cancer - Kidney Cancer - Lung Cancer - Lymphoma - Metastatic Cancer - Multiple Myeloma - Parathyroid Neoplasms - Renal Cancer - Thyroid Cancer - Hodgkin's Lympho
9 Locations available
- A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer
1 Location available
- Tissue Repository for Correlation of Molecular Markers With Response to Neoadjuvant and Metastatic Chemotherapy
Conditions: Breast Cancer
2 Locations available
- Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Conditions: Squamous Cell Cancer - Head and Neck Cancer
5 Locations available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer - Head and Neck Cancer - Breast Cancer - Non-small Cell Lung Cancer - Colorectal Cancer - Pancreatic Cancer - Ovarian Cancer - Esophageal Cancer - Gliomas
1 Location available
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
19 Locations available
- Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer
Conditions: Pancreatic Cancer - Periampullary Adenocarcinoma
1 Location available
- Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- High-Dose Methotrexate and Liposomal Cytarabine in Treating Patients With Central Nervous System (CNS) Metastases From Breast Cancer
Conditions: Stage IV Breast Cancer - Central Nervous System Involvement/Metastases - Leptomeningeal Metastases - Recurrent Breast Cancer - Tumors Metastatic to Brain
1 Location available
- Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer
2 Locations available
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
286 Locations available
- Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Women With HER2/Neu-Negative Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
13 Locations available
- Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer
Conditions: Prostate Cancer - Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- Gemcitabine Hydrochloride With or Without GDC-0449 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer
24 Locations available
- Phase II Study of Tesetaxel in Metastatic Melanoma
Conditions: Advanced Melanoma - Cancer
1 Location available
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2 - Male Breast Cancer - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer - Stage IIIC Breast Cancer - Stage
1 Location available
- A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic B
Conditions: Breast Cancer
6 Locations available
- GDC-0449 and RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Gastrointestinal Stromal Tumor - Kidney Cancer - Malignant Neoplasm of Conjunctiva - Ovarian Cancer - Sarcoma - Small Intestine Cancer
1 Location available
- Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Esophagus - Adenocarcinoma of the Gastroesophageal Junction - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Recurrent Esophageal Cancer - Recurrent Gastric Ca
1 Location available
- A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Canc
Conditions: Metastatic Colorectal Cancer
1 Location available
- Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer
37 Locations available
- Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
Conditions: Breast Cancer
1 Location available
- Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer - Gastroesophageal Junction Cancer
1 Location available
- Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
13 Locations available
- Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
Conditions: Breast Cancer
1 Location available
- Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
1 Location available
- Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
Conditions: Esophageal Cancer - Gastric Cancer
18 Locations available
- Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
4 Locations available
- Pilot Study Using Molecular Profiling to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer.
Conditions: Metastatic Breast Cancer
3 Locations available
- Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer
1 Location available
- MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Conditions: HER2 Amplified Breast Cancer - Metastatic or Advanced Breast Cancer
3 Locations available
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Cancers
3 Locations available
- Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Conditions: Breast Cancer
5 Locations available
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
253 Locations available
- Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Canc
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
188 Locations available
- Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer - Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Recurrent Prostate Cancer - Stage IV Prostate Cancer
1 Location available
- Azacitidine and CAPOX in Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
1 Location available
- Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
1 Location available
- A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
Conditions: Prostate Cancer
2 Locations available
- Treating Metastatic Cancer With Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes
Conditions: Metastatic Cancer - Metastatic Melanoma - Renal Cancer
1 Location available
- GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas - Advanced Solid Tumors - Cancer - Cancer of Pancreas - Cancer of the Pancreas - Metastases - Metastatic Cancer - Metastatic Pancreatic Cancer - Pancreas Cancer - Pancreatic Cancer - Bone Metastases - Endocrine Cancer - Onco
23 Locations available
- Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Conditions: Head and Neck Cancer
22 Locations available
- TKI258 for Metastatic Inflammatory Breast Cancer Patients
Conditions: Breast Cancer
1 Location available
- Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
9 Locations available
- Lapatinib Ditosylate and MK2206 in Treating Women With Metastatic Breast Cancer
Conditions: Breast Cancer
3 Locations available
- A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squ
Conditions: Lung Cancer, Small Cell
10 Locations available
- Characterization of Circulating Tumor Cells (CTCs) to Direct Pre-Operative and Systemic Therapy in Patients With Locally Advanced or Metastatic Stage
Conditions: Locally Advanced Breast Cancer - Metastatic (Stage IV) Breast Cancer - Stage III-IV Breast Cancer or Inflammatory
1 Location available
- A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary
Conditions: HLRCC - Metastatic Papillary RCC
1 Location available
- Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Tesetaxel as First-line Therapy for Metastatic Breast Cancer
Conditions: Breast Neoplasm
2 Locations available
- Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
Conditions: Adenocarcinoma of the Esophagus - Diffuse Adenocarcinoma of the Stomach - Intestinal Adenocarcinoma of the Stomach - Mixed Adenocarcinoma of the Stomach - Stage IV Esophageal Cancer - Stage IV Gastric Cancer
2 Locations available
- Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breas
Conditions: Breast Cancer
11 Locations available
- Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
Conditions: Advanced Solid Tumors - Metastatic Colorectal Cancer
1 Location available
- Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: Anal Cancer - Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Nonneoplastic Condition - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Veliparib and Carboplatin in Treating Women With HER2-Negative Metastatic Breast Cancer
Conditions: Breast Cancer
3 Locations available
- Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
Conditions: Breast Cancer
7 Locations available
- Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer
Conditions: Metastatic Colorectal Cancer
1 Location available
- Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Conditions: Adenocarcinoma of the Prostate - Hormone-resistant Prostate Cancer - Recurrent Prostate Cancer - Stage IV Prostate Cancer
4 Locations available
- Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer
1 Location available
- Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
11 Locations available
- Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in K-RAS/BRAF Mutant Metastatic Colorectal Cancer
Conditions: Colorectal Cancer Metastatic
15 Locations available
- Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Conditions: Breast Cancer
2 Locations available
- Monoclonal Antibody to OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer
Conditions: Prostate Cancer Metastatic - Cancer of the Prostate - Prostate Cancer
1 Location available
- A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Locally Advanced or Metastatic Breast or Colorectal Cancer
3 Locations available
- Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type KRAS Who Ha
Conditions: Metastatic Colorectal Cancer
5 Locations available
- Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer - Prostate Cancer
3 Locations available
- Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Conditions: Biliary Cancer - Cholangiocarcinoma
1 Location available
- Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma)
Conditions: Hepatocellular Carcinoma
1 Location available
- ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Subjects With KRAS Wild-Type Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer
3 Locations available
- Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial
Conditions: Endometrial Cancer - Gastrointestinal Carcinoid Tumor - Islet Cell Tumor - Liver Cancer - Lung Cancer - Ovarian Cancer
6 Locations available
- Trial of LBH589 in Metastatic Thyroid Cancer
Conditions: Thyroid Carcinoma
2 Locations available
- A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
Conditions: Melanoma - Carcinoma, Renal Cell
1 Location available
- Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Renal Cell Carcinoma - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
1 Location available
- Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Conditions: Metastatic Non Small Cell Lung Cancer - Metastatic Breast Cancer
1 Location available
|